The Pharmacy Commission released its second draft rule for sterile compounding Aug. 11. The draft rule aims to provide minimum standards for all licensed facilities that compound sterile drugs. Hospitals and health systems can comment on the draft rule here through Sept. 30.
WSHA had a number of concerns with the initial draft and worked closely with the State Pharmacy Association to submit joint comments to the Pharmacy Commission in February. Though further review is needed, WSHA is concerned with the nature and direction of the second draft. We will convene our members to address these concerns and provide comments.
For more information, contact Ian Corbridge to become more involved in this or other pharmacy issues. (Ian Corbridge)
